🧫
Acat1 knockdown functional validation experiment
active
experiment
Created: 2026-04-10T22:48:36
By: etl-v1-backfill
Quality:
50%
✓ SciDEX
ID: exp-3cd8a1ca-69f3-4835-a4ef-ee7a8fe1ce0b
🧫 Experiment Protocol
Exploratorychronic kidney diseaseACAT1Acat1 knockdown cells/tissuesproposed
Gene knockdown experiments were performed to validate the functional importance of ACAT1 in hyperoside's renoprotective effects. ACAT1 expression was reduced using molecular techniques, and the impact on hyperoside's metabolic and mitochondrial benefits was assessed. This loss-of-function approach confirmed that ACAT1 is necessary for hyperoside's therapeutic effects on fatty acid oxidation, mitochondrial function, and fibrosis reduction. The experiment provided crucial mechanistic evidence linking ACAT1 to hyperoside's mode of action.
PRIMARY OUTCOME
loss of hyperoside's metabolic and mitochondrial benefits
EXPECTED OUTCOMES
ACAT1 knockdown would abolish hyperoside's protective effects
SUCCESS CRITERIA
significant reduction in hyperoside efficacy upon ACAT1 knockdown
PROTOCOL
ACAT1 knockdown, hyperoside treatment, assessment of metabolic flux and mitochondrial function
Source: PMID 41903436 ↗
🧫 Experiment Extras
PATHWAY
ACAT1-l-carnitine-SIRT3 axis, fatty acid oxidation
MARKET PRICE
$0.50
STATUS
proposed
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | experiments |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.